hypermenorrhea. Excessive and frequent menstruation with regular cycle
Conditions
Interventions
Intervention 1: Syrup (drug), 3 times daily for a week starting menstruation, 1 tablespoon each half hour after meal. The trend for 3 menstrual cycles (every month for 7 days) is repeated. Interventio
Treatment - Drugs
Placebo
Syrup (placebo), 3 times daily for a week starting menstruation, 1 tablespoon each half hour after meal. The trend for 3 menstrual cycles (every month for 7 days) is repeated.
Syrup (drug), 3 times daily for a week starting menstruation, 1 tablespoon each half hour after meal. The trend for 3 menstrual cycles (every month for 7 days) is repeated.
Sponsors
Medical faulty, Shahed University
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patient satisfaction; outpatients aged 20- 55 years with excessive uterine bleeding that have a negative pregnancy test and they are not lactating; Endometrial thickness in ultrasound is normal; Gynecologic examination is normal; The Pap smear is normal; concurrent hormonal therapy, herbal and other medicinal plants are not used; there are no chronic disease like diabetes, lupus and thyroid problems; there is no organic disease such as uterus or ovaries or other malignancies; Intramural fibroids larger than 5 cm sub mucosal or not; Bleeding is more than 7 days and or Course is less than 21 days. Exclusion criteria: use of hormonal drugs in the study; Use of mefenamic acid in the study; Patients who are experiencing possible side effects; Patients who require surgical intervention and have the other; Patients with a personal request to withdraw from the study; bleeding during the study is so severe that emergency action is required.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual period duration. Timepoint: at the end of each cycle. Method of measurement: Questionnaire.;Intensity of menstrual bleeding. Timepoint: at the end of each cycle. Method of measurement: Questionnaire.;Hemoglobin. Timepoint: before & after the study. Method of measurement: cell counter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effect. Timepoint: at the end of study. Method of measurement: questionniare. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed